The need for better data about counterfeit drugs in developing countries: A proposed standard research methodology tested in Chennai, India

Journal of Clinical Pharmacy and Therapeutics

Volumn 36, Issue 4, 2011, Pages 488-495

  Seear, M ^a,b   Gandhi, D ^a   Carr, R ^b   Dayal, A ^c   Raghavan, D ^c   Sharma, N ^c  

^a Centre for International Child Health   (Canada)

^b CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

^c APOLLO HOSPITALS   (India)

Author keywords

developing countries; drug counterfeiting; drug quality

Indexed keywords

ARTESUNATE; CIPROFLOXACIN; COUNTERFEIT DRUG; RIFAMPICIN;

ARTICLE; DEVELOPING COUNTRY; DRUG COST; DRUG DECOMPOSITION; DRUG DETERMINATION; DRUG MANUFACTURE; DRUG MARKETING; DRUG PACKAGING; DRUG QUALITY; DRUG STORAGE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PHARMACY; PRESCRIPTION; QUALITY CONTROL; TABLET FORMULATION;

ARTEMISININS; CHROMATOGRAPHY, LIQUID; CIPROFLOXACIN; COUNTERFEIT DRUGS; DEVELOPING COUNTRIES; DRUG CONTAMINATION; DRUG STABILITY; DRUG STORAGE; HUMANS; INDIA; MASS SPECTROMETRY; QUALITY CONTROL; RESEARCH DESIGN; RIFAMPIN;

EID: 79960090716     PISSN: 02694727     EISSN: 13652710     Source Type: Journal    
DOI: 10.1111/j.1365-2710.2010.01198.x     Document Type: Article

References (34)

1. Lee M, (2002) Plants against malaria. Part 1: Cinchona or the Peruvian bark. The Journal of the Royal College of Physicians of Edinburgh, 32, 189-196.
2. Wax P, (1995) Elixirs, diluents and the passage of the 1938 Federal Food, Drug and Cosmetic Act. Annals of Internal Medicine, 122, 456-461.
3. Montoya I, Jano E, (2007) Online pharmacies: safety and regulatory considerations. International Journal of Health Services, 37, 279-289. (Pubitemid 47258132)
4. Amin A, Kokwaro G, (2007) Antimalarial drug quality in Africa. Journal of Clinical Pharmacy and Therapeutics, 32, 429-440. (Pubitemid 47404284)
5. Kelesidis T, Kelesidis I, Rafailidis P, Falagas M, (2007) Counterfeit or substandard antimicrobial drugs: a review of the scientific evidence. Journal of Antimicrobial Chemotherapy, 60, 214-236. (Pubitemid 47248427)
6. Newton P, Green M, Fernandez F, Day N, White N, (2006) Counterfeit anti-infective drugs. Lancet Infectious Diseases, 6, 602-613.
7. Rudolph P, Bernstein I, (2004) Counterfeit drugs. New England Journal of Medicine, 350, 1384-1386. (Pubitemid 38419991)
8. Cockburn R, Newton P, Agyarko E, Akunyili D, White N, (2005) The global threat of counterfeit drugs: why industry and governments must communicate the dangers. PLoS Medicine, 2, 302-308.
9. Mukerjee A, (2003) Pills that kill. Outlook (Mumbai) Sept 22, 9-15.
10. Fackler M, (2002) China's fake drugs kill thousands. San Francisco Examiner July 29, 19.
11. Cockburn R, Newton P, Agyarko E, Akunyili D, White N, (2007) Correction: the global threat of counterfeit drugs. PLoS Medicine, 4, 1553.
12. Bate R, Tren R, Mooney L, Hess K, Mitra B, Debroy B, Attaran A, (2009) Pilot study of essential drug quality in two major cities in India. PLoS One, 4, 1-5.
13. World Health Organization (2006) Counterfeit medicines. Geneva: WHO Fact Sheet no 275; November.
14. International Medical Products Anti-Counterfeiting Taskforce (2006) Counterfeit medicines: an update on estimates. IMPACT Fact Sheet, November.
15. Dondorp A, Newton P, Mayxay M, Van Damme W, Smithuis F, Yeung S, et al. (2004) Fake anti-malarials in Southeast Asia are a major impediment to malaria control: multinational cross-sectional survey on the prevalence of fake anti-malarials. Tropical Medicine and International Health, 9, 1241-1246. (Pubitemid 40037159)
16. Wondemagegenhu E, (1999) Counterfeit and substandard drugs in Myanmar and Vietnam. EDM Research Series, QSM/99.3. Geneva: WHO.
17. Newton P, Lee S, Goodman C, Fernandez F, Yeung S, Phanouvong S, et al. (2009) Guidelines for field surveys of the quality of medicines: a proposal. PLoS Medicine, 6, 252-257.
18. Taylor R, Shakoor O, Behrens R, Everard M, Low A, Wangboonskul J, et al. (2001) Pharmacopoeial quality of drugs supplied by Nigerian pharmacies. Lancet, 357, 1933-1936. (Pubitemid 32568335)
19. Government of India (2003) A comprehensive examination of drug regulatory issues, including the problem of spurious drugs. Available at: (accessed 5 February 2010).
20. Hall K, Newton P, Green M, De Veij M, Vandenabeele P, Pizzanelli D, et al. (2006) Characterization of counterfeit artesunate antimalarial tablets from Southeast Asia. American Journal of Tropical Medicine and Hygiene, 75, 804-811. (Pubitemid 351627522)
21. Lim C-K, Lord G, (2002) Current developments in LC-MS for pharmaceutical analysis. Biological and Pharmaceutical Bulletin, 25, 547-557. (Pubitemid 39663247)
22. Caudron J-M, Ford N, Henkens M, Macé C, Kiddle-Monroe R, Pinel J, (2008) Substandard medicines in resource-poor settings: a problem that can no longer be ignored. Tropical Medicine and International Health, 13, 1062-1072.
23. Wertheimer A, Chaney M, Santella T, (2003) Counterfeit pharmaceuticals: current status and future projections. Journal of the American Pharmaceutical Association, 43, 710-718.
24. Khan A, Ghilzai N, (2007) Counterfeit and substandard quality of drugs: the need for effective regulatory control in India and other developing countries. Indian Journal of Pharmacology, 39, 206-207. (Pubitemid 350005996)
25. Mudur G, (2003) India to introduce death penalty for peddling fake drugs. British Medical Journal, 327, 414.
26. Menkes D, (1997) Hazardous drugs in developing countries. British Medical Journal, 315, 1557-1558. (Pubitemid 27522394)
27. Shakoor O, Taylor R, Behrens R, (1997) Assessment of the incidence of substandard drugs in developing countries. Tropical Medicine and International Health, 2, 839-845. (Pubitemid 27396011)
28. Gaudiano M, Di Maggio A, Cocchieri E, Antoniella E, Bertocchi P, Alimonti S, et al. (2007) Medicines informal market in Congo, Burundi and Angola: counterfeit and sub-standard antimalarials. Malaria Journal, 6, 22-31.
29. Kyriacos S, Mroueh M, Chahine R, Khouzam O, (2008) Quality of amoxicillin formulations in some Arab countries. Journal of Clinical Pharmacy and Therapeutics, 33, 375-379.
30. Newton P, Proux S, Green M, Smithuis F, Rozendaal J, Prakongpan S, et al. (2001) Fake artesunate in southeast Asia. Lancet, 357, 1948-1950. (Pubitemid 32568341)
31. Newton P, White N, Rozendaal J, Green M, (2002) Murder by fake drugs. British Medical Journal, 324, 800-801.
32. Green M, Dwight L, Wirtz R, White N, (2000) A colorimetric field method to assess the authenticity of drugs sold as the antimalarial artesunate. Journal of Pharmaceutical and Biomedical Analysis, 24, 65-70.
33. Fernandez F, Green M, Newton P, (2008) Prevalence and detection of counterfeit pharmaceuticals: a mini review. Industrial & Engineering Chemistry Research, 47, 585-590.
34. Rivier L, (2003) Criteria for the identification of compounds by liquid chromatography-mass spectrometry and liquid chromatography-multiple mass spectrometry in forensic toxicology and doping analysis. Analytica Chimica Acta, 492, 69-76.